approval · primary record
CILASTATIN SODIUM
FDA · NDA · 2025-12-09
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-12-09 |
| Brand | RECARBRIO |
| Sponsor | MSD MERCK CO |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:43.065Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CILASTATIN SODIUM:2025-12-09
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.